Skip to main content
OpenTrials

Clinical trial condition

Neuroectodermal Tumors

Explore clinical trials studying Neuroectodermal Tumors. Study availability and eligibility vary by location and protocol.

6,006 public trials 1,218 recruiting studies
Refine in advanced search Browse all conditions

Neuroectodermal Tumors trial results

Completed

A Study in Recurrent Glioblastoma (GB)

NCT01582269

Conditions
Astrocytoma, Glioblastoma, Glioma, +7 more
Locations
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Birmingham, Alabama, United States
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. La Jolla, California, United States
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. San Francisco, California, United States
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Cleveland, Ohio, United States
View all 29 locations
View Trial Details
Completed

MGMT-NET: O6-methylguanine-DNA Methyltransferase (MGMT) Status in Neuroendocrine Tumors: Predictive Factor of Response to Alkylating Agents

NCT03217097

Conditions
Neoplasms, Neoplasms by Histologic Type, Neoplasms, Germ Cell and Embryonal, +3 more
Locations
  • Hôpital Sud - CHU Amiens Amiens, France
  • CHU d'Angers Angers, France
  • Hôpital Estaing, CHU de Clermont-Ferrand Clermont-Ferrand, France
  • Hôpital Beaujon - APHP Clichy, France
View all 19 locations
View Trial Details
Completed

A Study to Characterize the Safety, Tolerability, and Preliminary Efficacy of CFT1946 as Monotherapy and Combination Therapy in Subjects With BRAF V600 Mutant Solid Tumors

NCT05668585

Conditions
ATC, CRC, Melanoma, +13 more
Locations
  • University of Arizona - Cancer Center Tucson, Arizona, United States
  • Florida Cancer Specialists Sarasota, Florida, United States
  • Community Health Network Indianapolis, Indiana, United States
  • Dana-Farber Cancer Institute Boston, Massachusetts, United States
View all 26 locations
View Trial Details
Completed

First-line Treatment of Ewing Tumours With Primary Extrapulmonary Dissemination in Patients From 2 to 50 Years (CombinaiR3)

NCT03011528

Conditions
Ewing Sarcoma Family of Tumors, Neoplasms, Neoplasms by Histologic Type, +7 more
Locations
  • Chr Felix Guyon La Réunion, Saint Denis, France
  • Bordeaux Chu Bordeaux, France
  • CHU Grenoble Alpes Grenoble, France
  • LILLE Centre Oscar Lambret Lille, France
View all 17 locations
View Trial Details
Completed

Intratumoral Injection of LTX-315 in Combination With Pembrolizumab in Advanced Melanoma

NCT04796194

Conditions
Advanced Melanoma, Melanoma, Neoplasms, +10 more
Locations
  • Icahn School of Medicine at Mount Sinai New York, United States
  • Levine Cancer Institute - Atrium Health Charlotte, North Carolina, United States
  • University of Pittsburgh Medical Center (UPMC) Hilman Cancer Center Pittsburgh, Pennsylvania, United States
  • MD Anderson Cancer Centre Houston, Texas, United States
View Trial Details

Related conditions